DCPH Archives - Spark Newswire

1 minute read

Deciphera Pharmaceuticals Sees Renewed Competitive Edge After Theseus Pan-KIT Discontinuation: Analyst

August 10, 2:09 PM

Stifel upgraded Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) to Buy from Hold, with a price target of $20 from $14, after reevaluating the competitive landscape for the 2L GIST market.

DCPH

11 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For August 10, 2023

By Benzinga Insights

August 10, 11:00 AM

Upgrades For Roblox Corp (NYSE:RBLX), Wedbush upgraded the previous rating of Neutral to Outperform. Roblox earned $0.46 in…

ADCT

2 minute read

Global Payments To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Thursday

By Lisa Levin

August 10, 7:53 AM

Keybanc cut the price target for i3 Verticals, Inc. (NASDAQ: IIIV) from $28 to $26. Keybanc analyst Josh Beck maintained an Overweight rating. i3 Verticals shares fell 2.9% to close at $22.76 on Wednesday.

ARHS

22 minute read

Earnings

Earnings Scheduled For August 9, 2023

By Benzinga Insights

August 9, 4:54 AM

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is estimated to report quarterly earnings at $0.96 per share on revenue of $18.11 billion.

AADI

2 minute read

Analyst Ratings

The Latest Analyst Ratings for Deciphera Pharmaceuticals

By Benzinga Insights

May 4, 4:01 PM

Deciphera Pharmaceuticals (NASDAQ:DCPH) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

DCPH

1 minute read

Earnings

Preview: Deciphera Pharmaceuticals’s Earnings

By Benzinga Insights

May 2, 2:01 PM

Deciphera Pharmaceuticals (NASDAQ:DCPH) is set to give its latest quarterly earnings report on Wednesday, 2023-05-03. Here’s what investors…

DCPH

1 minute read

Stifel Is Bullish On This ‘Competitive Late-Comer’ In Gastric Cancer Space

By Vandana Singh

March 16, 1:47 PM

Stifel has initiated coverage on Theseus Pharmaceuticals Inc (NASDAQ:THRX) with a Buy rating and a $24 price target. The company’s Predictive Resistance…

DCPH